Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Integral Diagnostics Ltd. ( (AU:IDX) ) has issued an announcement.
Integral Diagnostics Limited announced the release of 876,068 fully paid ordinary shares from voluntary escrow on November 1, 2025. This release will not affect the company’s issued capital, indicating a stable financial position and potentially reassuring stakeholders about the company’s operational consistency.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$4.00 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services in Australia and New Zealand, employing top radiologists and diagnostic imaging specialists. The company operates under a unique medical leadership model focused on quality patient care, service, and access.
Average Trading Volume: 1,146,193
Technical Sentiment Signal: Hold
Current Market Cap: A$965.9M
See more data about IDX stock on TipRanks’ Stock Analysis page.